Clinical Pharmacological Approach To The Use Of Hypolipidemic Drugs In The Treatment Of Atherosclerotic Disease

Authors

  • Sobirjonov I.T. Assistant of the Department of pharmacology, clinical pharmacology and medical biotechnology ASMI

DOI:

https://doi.org/10.62480/tjms.2025.vol42.pp39-41

Keywords:

arterial hypertension, chronic obstructive pulmonary disease, dyslipidemia

Abstract

To evaluate the hypolipidemic effect, the impact on endothelial function, oxidative stress of pitavastatin at a dose of 4 mg in patients with dyslipidemia, arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) at baseline, in dynamics after 4 weeks and 12 months of treatment. The prospective study included 33 patients (mean age – 60 years) with hypertension, COPD and dyslipidemia. Laboratory examination consisted of determining the lipid spectrum, the level of lipid peroxidation products (LPO). In order to assess the tolerability of the prescribed therapy, creatinine, bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST) were studied

References

Chazova I.E., Lazareva N.V., Oshchepkova E.V. Arterial hypertension and chronic obstructive

pulmonary disease: clinical characteristics and treatment effectiveness (according to the National

Registry of Arterial Hypertension). Therapeutic archive. 2019;91(3): 4-10. doi: 10.2

/00403660.2019.03.000110

2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the

management of arterial hypertension of the European Society of Cardiology (ESC) and the European

Society of Hypertension (ESH). European Heart Journal. 2018;39(33):3021-3104. doi:

1093/eurheartj/ ehy339.

Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I., et

al. Arterial hypertension in adults. Clinical guidelines 2020. Russian journal of cardiology.

;25(3):3786. doi: 10.15829/1560-4071-2020-3-3786

Karoli, N.A., Rebrov A.P. Chronic obstructive pulmonary disease and arterial hypertension: vascular

wall as a target organ in comorbid patients. Rational pharmacotherapy in cardiology.

;13(4):513-518. doi: 10.20996/1819-6446-2017-13-4-513-518

Tomiyama, H. Ishizu T., Kohro R. Longitudinal association among endothelial function, arterial

stiffness and subclinical organ damage in hypertension. Int. J. Cardiol. 2018;253:161-166. doi:

1016/j.ijcard.2017.11.022

Downloads

Published

2025-03-13

Issue

Section

Articles

How to Cite

Clinical Pharmacological Approach To The Use Of Hypolipidemic Drugs In The Treatment Of Atherosclerotic Disease. (2025). Texas Journal of Medical Science, 42, 39-41. https://doi.org/10.62480/tjms.2025.vol42.pp39-41